logo-loader
viewCello Health PLC

Cello Health PLC - Block listing Interim Review

RNS Number : 6423A
Cello Health PLC
22 January 2020
 

22 January 2020

Cello Health plc

("Cello" or the "Company")

Block Listing Update

Total Voting Rights

 

The Company notifies that, since the date of its most recent block listing update, a total of 1,232,928 new ordinary shares of 10p each in the share capital of the Company have been issued and allotted (pursuant to the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010) and admitted to trading in accordance with the block listing. An update in accordance with Schedule 6 of the AIM Rules for Companies is set out below.

 

As at today's date, Cello's issued share capital comprises 106,778,473 ordinary shares of 10 pence each ("Ordinary Shares"), of which 453,000 Ordinary Shares are held in treasury. The total number of current voting rights in the Company is therefore 106,325,473 Ordinary Shares, which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquires

Cello Health

020 7812 8460

Mark Scott, Chief Executive

 

Mark Bentley, Group Finance Director

 

Cenkos Securities

  020 7397 8900

Giles Balleny

 

Harry Hargreaves

 

Buchanan

  020 7466 5000

Mark Court

 

Jamie Hooper

 

Sophie Wills

 

 

BLOCK LISTING SIX MONTHLY RETURN

Name of applicant:

Cello Health plc

Name of scheme:

PSP Option Scheme 2010, Approved Share Option Plan 2009 and Unapproved Scheme 2010

Period of return:

From:

23 May 2019

To:

21 January 2020

Balance of unallotted securities under scheme(s) from previous return:

2,918,747

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(1,232,928)

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1,685,819

Name of contact:

Mark Bentley, Group Finance Director

Telephone number of contact:

020 7812 8460

         

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BLRFLFVRLAIFFII

Quick facts: Cello Health PLC

Price: 110

Market: AIM
Market Cap: £117.36 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Cello Health PLC running 'remarkably well' since going completely virtual

Cello Health PLC's (LON:CLL) Mark Scott tells Proactive's Andrew Scott they're coping well since first going completely remote and virtual. ''It's a lot of people, a thousand people, and we've done that successfully, all operating well and we've maintained a large number of global...

on 7/4/20